Proliferating cell nuclear antigen (PCNA), an endogenous nuclear protein, has recently been used to identify replicating cells. PCNA was compared to tritiated thymidine ([3Hl-TdR), a reliable and accurate exogenous labeling agent, to ascertain if PCNA gives comparable results for quantitative cell proliferation. Male F344 rats were treated with a single dose of 500 mg/kg 4-acetylaminofluorene (4-AAF), a known liver mitogen. Rats (n = 5) were euthanized and necropsied at 6, 12, 18, 24, 36, 48, 96, or 192 hr after treatment. Two hours before necropsy, rats were pulse-dosed with [3H]-TdR (2 mCi/kg body weight). Livers were sectioned, autoradiography performed, and labeling indexes (LI), a measurement of the percentage of S-phase hepatocytes, determined. One and a half years after the completion of this study, the archival paraffin blocks of the liver tissue were sectioned and stained for PCNA by an immunohistochemical procedure. Immunocytochemical staining patterns of proliferating cell nuclear antigen expression 
Introduction
Proliferating cell nuclear antigen (PCNA), an endogenous nuclear protein, has recently been used to identify replicating cells in human and rodent tissues (1) (2) (3) (4) (5) (6) (7) (8) (9) . The PCNA amino acid sequence in the rat and human differs by four residues, indicating a highly conserved molecule (10) . This 36-kD protein functions as an accessory protein to DNA polymerase (pol) 6 (11, 12) . DNA pol 6, in conjunction with PCNA, is also responsible for leading strand DNA synthesis in replicating cells, whereas PCNA involved in DNA repair mechanisms is independent of DNA pol 6 (13) . Studies of cells in culture have identified PCNA in G1, S, G2, and M phases of the cell cycle with peak expression of the protein during S phase (14) (15) (16) . The advent of commercially available antibodies of PCNA has allowed the immunohistochemical detection and evaluation of this endogenous cell-cycle-related protein as a marker of replicating cells, which is of particular importance with the recent interest in the role of cell proliferation in chemical carcinogenesis (17, 18) .
Limited data exist that use PCNA for assessment of chemically induced cell proliferation in rodent tissues.
The use of PCNA immunohistochemistry in rodent studies depends on its sensitivity, reproducibility, and comparability to other markers of cell proliferation. In this report, we describe a) PCNA (20) . Modifications to this staining procedure, described here in detail, were used to eliminate background staining.
PCNA Staining Procedure
This procedure applied to tissues fixed in 10% NBF for extended periods of time (greater than 72 hr).
Liver tissues were sectioned at 6 gm and mounted on tissue adhesive poly-l-lysine coated slides. Sections were air dried, deparaffinized in xylene, and hydrated through a graded series of ethyl alcohols to 1X Automation Buffer, pH 7.5 (Biomeda Corporation, Foster City, CA). A highly sensitive biotin-streptavidin method of immunohistochemical localization was performed as follows (see Table 1 These kits may be purchased concentrated or prediluted. If using the concentrated kits, the link and label antibody are diluted with 1% BSA in 1X automation buffer at a 1:10 dilution.
13. Rinse slides briefly with distilled water and remove excess liquid from the surface of the slide. 14. Apply diaminobenzidine (DAB) solution to the tissue sections.
Incubate 
Results
The modified immunostaining procedure yielded consistent staining patterns, limited background chromogen staining, and allowed the reliable identification of G,, S, G2, M, and Go hepatocytes. Initial attempts using a previously described procedure (20) produced inconsistent staining, increased background, and complications in discriminating cell cycle phases. By reducing the microwave time (i.e., heat exposure), consistent staining was obtained with minimal background. Tissues fixed in formalin for several months required longer microwave incubation to permit optimal expression of the PCNA antigen (data not shown). Since the tissue in this experiment was fixed for a shorter time period (approximately 2 to 3 weeks), decreased microwave irradiation was apparently required to permit select PCNA antigen expression without background staining.
PCNA antigen-antibody complexes expressed various staining patterns. The staining results were categorized based on cellular distribution and intensity of the reaction product as shown in Table 2 and as previously described by Foley et al. (8) . Go or quiescent hepatocytes expressed no detectable staining. GI hepatocytes were characterized by a patchy to uniform, light-brown nuclear staining. Cells in S phase displayed uniform intense brown to black nuclear staining. Diffuse speckled-brown nuclear and cytoplasmic staining characterized hepatocytes in the G2 phase. Mitotic hepatocytes had diffuse and speckled-brown cytoplasmic staining.
The growth fraction revealed that the majority of hepatocytes were G, hepatocytes at 6, 12, and 18 hr after 4-AAF treatment (Fig 1) . For the next 32 hr, 78% of the cells were active in the cell cycle, dropping to 45% at the 96 hr interval. The proportion of actively cycling cells returned to 3% at 192 hr. The individual cell cycle phases of the growth fraction, as detected by PCNA expression after 4-AAF exposure, are also shown in Figure 1 . The proportion of GI hepatocytes was elevated after 24 hr (40%) and remained at peak levels through the 96 hr (43%) interval before declining to 3% at 192 hr. S-phase hepatocytes increased after 24 hr (23%) and remained elevated at 36 and 48 hr (17% and 28%, respectively). At 96 and 192 hr, the proportion of S-phase cells had declined to less than 2%. The percentage of actively cycling cells that were G2-and M-phase hepatocytes was greatest at 36 hr (21% and 4% respectively). At all other time points, less than 1% of the G2-and M-phase cells accounted for the total percentage of actively cycling hepatocytes. It is evident that 4-AAF treatment greatly altered the hepatocyte growth fraction ( Fig. 1 and 2 PCNA (19A2) has also allowed for the estimation of the growth fraction in liver tissue. We observed a time-dependent alteration in the hepatic growth fraction curve as a consequence of 4-AAF treatment. Information gained from the ability to estimate the growth fraction will help with the understanding of cell-cycle kinetics in normal and neoplastic tissue.
Many investigators have attempted to ascertain the validity of PCNA as an indicator of cell proliferation by comparing PCNA to other markers such as [3H]-TdR, BrdU, and Ki67 (3) (4) (5) 7, 9, 22) . Most of the correlations have yielded good results with few exceptions (7, 23, 24) . Further investigation is warranted to understand if the discrepancies noted in the exceptions are related to PCNA gene regulation, PCNA expression in different cell types, and/or differences in the antigenicity of anti-PCNA antibodies (25) . Variables in experimental conditions including the use of different tissue fixatives (formalin versus methanol) may result in a lack of correlation between proliferation markers (4, 7, (25) (26) (27) (28) 
